Shao Guangzhao, Zhi Yao, Fan Zhongqi, Qiu Wei, Lv Guoyue
Department of Hepatobiliary and Pancreatic Surgery, First Hospital of Jilin University, Changchun, Jilin, China.
Front Med (Lausanne). 2023 Jul 19;10:1171023. doi: 10.3389/fmed.2023.1171023. eCollection 2023.
Lung metastasis (LM) is a common occurrence in patients with hepatocellular carcinoma (HCC), and it is associated with a poorer prognosis compared to HCC patients without LM. This study aimed to identify predictors and prognostic factors for LM in HCC patients as well as develop diagnostic and prognostic nomograms specifically tailored for LM in HCC patients.
A retrospective analysis was conducted on HCC patients from the Surveillance, Epidemiology, and End Results (SEER) database, covering the period from 2010 to 2015. The study employed multivariate logistic regression analysis to identify risk factors associated with LM in HCC patients. Additionally, multivariate Cox proportional hazards regression analysis was utilized to investigate prognostic factors for HCC patients with LM. Subsequently, two nomograms were developed to predict the risk and prognosis of LM in HCC patients. The performance of the nomograms was evaluated through calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA).
This retrospective study included a total of 5,934 patients diagnosed with HCC, out of which 174 patients were diagnosed with LM. Through multivariate logistic regression analysis, several independent risk factors for LM in HCC patients were identified, including tumor grade, tumor size, American Joint Committee for Cancer (AJCC) T stage, and AJCC N stage. Furthermore, multivariate Cox analysis revealed that tumor grade, delayed treatment, surgery, and radiation were independent prognostic factors for HCC patients with LM. To assess the predictive power of the developed nomograms, calibration curves, receiver operating characteristic (ROC) analysis, and decision curve analysis (DCA) were employed. The findings demonstrated that the nomograms exhibited satisfactory performance in both the training and validation sets. Additionally, the prognostic nomogram effectively stratified HCC patients with LM into low- and high-risk groups for mortality.
These two nomograms optimally predicted the risk and prognosis of LM in HCC patients. Both nomograms have satisfactory performance. This would help clinicians to make accurate clinical decisions.
肺转移(LM)在肝细胞癌(HCC)患者中很常见,与无LM的HCC患者相比,其预后较差。本研究旨在确定HCC患者发生LM的预测因素和预后因素,并开发专门针对HCC患者LM的诊断和预后列线图。
对监测、流行病学和最终结果(SEER)数据库中2010年至2015年期间的HCC患者进行回顾性分析。该研究采用多因素逻辑回归分析来确定与HCC患者LM相关的危险因素。此外,利用多因素Cox比例风险回归分析来研究HCC合并LM患者的预后因素。随后,开发了两个列线图来预测HCC患者发生LM的风险和预后。通过校准曲线、受试者操作特征(ROC)曲线和决策曲线分析(DCA)对列线图的性能进行评估。
这项回顾性研究共纳入5934例诊断为HCC的患者,其中174例诊断为LM。通过多因素逻辑回归分析,确定了HCC患者发生LM的几个独立危险因素,包括肿瘤分级、肿瘤大小、美国癌症联合委员会(AJCC)T分期和AJCC N分期。此外,多因素Cox分析显示,肿瘤分级、延迟治疗、手术和放疗是HCC合并LM患者的独立预后因素。为了评估所开发列线图的预测能力,采用了校准曲线、受试者操作特征(ROC)分析和决策曲线分析(DCA)。结果表明,列线图在训练集和验证集中均表现出令人满意的性能。此外,预后列线图有效地将HCC合并LM的患者分为低死亡风险和高死亡风险组。
这两个列线图能最佳地预测HCC患者发生LM的风险和预后。两个列线图均表现出令人满意的性能。这将有助于临床医生做出准确的临床决策。